Prosecution Insights
Last updated: October 25, 2026

Szdc Law P.C.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

63 pending office actions • 28 clients • 58 examiners • 48 art units • 0 of 63 (0%) have an AI response strategy ready

Analysis

SZDC Law P.C. reports 1422 career applications in Biotechnology & Pharmaceuticals and 60 pending office actions. The figures show an established application history together with a substantial active office-action docket.

The resolved allowance rate is 88.67%, and the average is 1.92 office actions per allowance. Resolved matters have frequently reached allowance, with the reported allowances associated with fewer than multiple office-action events on average. This combination provides a clear view of both outcome frequency and prosecution interaction.

The profile is relevant for practitioners assessing a sizeable technology-focused portfolio. It does not identify application-specific claim scope, examiner assignments, or reasons for individual outcomes, so the metrics should support further diligence rather than serve as a standalone forecast.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1422 apps, methodology: how we score firms)

88.7%
Allowance Rate
n=1422
+0.61σ
Allowance Rate (norm)
n=1422
1.9
OAs to Allowance
n=970
-0.82σ
OAs to Allow (norm)
n=970
790 days
Time to Allowance
n=970
+5.2pp
Interview Lift
n=1422
11.3%
RCE Rate
n=1422
0.1%
Appeal Rate
n=1422

Rejection Performance (% of received rejections ultimately overcome)

70.3%
§101 Overcome
n=128
65.1%
§102 Overcome
n=321
64.3%
§103 Overcome
n=501
74.0%
§112 Overcome
n=646

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
14%
Top-3 CPC Share
n=1422
1
Practitioners
n=1422
1422.0
Apps / Practitioner
n=1422

Portfolio Summary

63
Total Pending OAs
32
Non-Final OAs
22
Final Rejections
9
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
1
Due this week
8
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

39
Hard (62%)
19
Medium (30%)
4
Easy (6%)
1
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 + other6 (10%)
§103 only16 (25%)
§112 only4 (6%)
Double-patenting + other3 (5%)
Multi-statute (no §101)33 (52%)
No statute on record1 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

51
Life Sciences
81% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
5
Semiconductors
8% of docket
7
Mechanical / Eng
11% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

630 h
Manual time on pending OAs
126 h
Time saved (low, 20%)
220 h
Time saved (mid, 35%)
5.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SCHWARTZ, PHILIP N 3 55.5% +17.0%
CARVALHO JR., ARMINDO 2 50.2% +27.6%
RHOADES, DEREK JAMES 2 72.3% +16.5%
KOROTCHKINA, LIOUBOV G 2 29.0% +64.1%
KELLY-O'NEILL, YOLANDA LYNNETTE 1 31.8% +23.7%
YE, XINWEN 1 43.1% +44.3%
BAKSHI, PANCHAM 1 76.7% +30.2%
CARREIRO, CAITLIN ANN 1 46.1% +38.4%
PAK, YONG D 1 74.7% +14.2%
EPSTEIN, TODD MATTHEW 1 60.8% +43.6%

Hard Cases (41)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17631439 TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF BUCKMASTER, MARLENE VRENI 239d overdue
17793009 4-UREIDO-5-CARBOXYL-IMIDAZOLE-AMIDE HYDROLASE AND USE THEREOF KOROTCHKINA, LIOUBOV G 74d overdue
18012321 SALVIA PLEBIA AND SCUTELLARIAE RADIX COMPOUND ACNE CREAM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF AMIN, ALPA NILESH 45d overdue
17772535 RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF RSV DISEASES USING THE SAME WRIGHT, SARAH C 30d overdue
18291564 INVERSION OF SOUND SPEED AND POISSON'S RATIO FROM ULTRASOUND BEAM DATA FOR CHARACTERIZATION OF TISSUES MACCHIAROLO, PETER J 9d overdue
19108416 ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA CARREIRO, CAITLIN ANN 3d overdue
18272084 ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME SCHWARTZ, PHILIP N 20d
18681042 FLOOR CLEANING SYSTEM CARLSON, MARC 21d

Interview Candidates (15)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17793009 4-UREIDO-5-CARBOXYL-IMIDAZOLE-AMIDE HYDROLASE AND USE THEREOF KOROTCHKINA, LIOUBOV G 74d overdue
19108416 ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA CARREIRO, CAITLIN ANN 3d overdue
18272084 ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME SCHWARTZ, PHILIP N 20d
18272083 ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME SCHWARTZ, PHILIP N 22d
19230200 CARDANOL-BASED BISPHENOL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF KELLY-O'NEILL, YOLANDA LYNNETTE —
19170179 METHOD FOR PREPARING IONOGEL FIBER BASED ON HALOGENOMETALLATE IONIC LIQUID YE, XINWEN —
19109585 SHIELDING COMPOUND, METHOD OF FORMING THIN FILM USING SHIELDING COMPOUND, AND SEMICONDUCTOR SUBSTRATE AND SEMICONDUCTOR DEVICE FABRICATED USING METHOD BAKSHI, PANCHAM —
19041885 COMPOSITE ENGINEERED BACTERIA AND METHOD FOR PRODUCING D-PSICOSE PAK, YONG D —

Client Portfolio (28 clients)

Top Art Units

Art UnitApps
16924
17493
17182
16522
16722
17612
16932
17292
17272
37232

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19230200 CARDANOL-BASED BISPHENOL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Nasurfar Biomaterial Technology (Changshu) Co., Ltd. KELLY-O'NEILL, YOLANDA LYNNETTE 1715 §103§112 Non-Final OA — Pending Jun 06, 2025
19170179 METHOD FOR PREPARING IONOGEL FIBER BASED ON HALOGENOMETALLATE IONIC LIQUID Soochow University YE, XINWEN 1754 §103 Final Rejection — Pending Apr 04, 2025
19109585 SHIELDING COMPOUND, METHOD OF FORMING THIN FILM USING SHIELDING COMPOUND, AND SEMICONDUCTOR SUBSTRATE AND SEMICONDUCTOR DEVICE FABRICATED USING METHOD Soulbrain Co., Ltd. BAKSHI, PANCHAM 1718 §102§112 Final Rejection — Pending Mar 07, 2025
19108416 ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA National University Corporation Tokyo Medical And Dental University CARREIRO, CAITLIN ANN 3786 §103§112 Final Rejection 3d overdue Pending Mar 03, 2025
19041885 COMPOSITE ENGINEERED BACTERIA AND METHOD FOR PRODUCING D-PSICOSE Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. PAK, YONG D 1652 §101§103§112DP Non-Final OA — Pending Jan 30, 2025
19041945 ENZYME COMBINATION, GENETICALLY ENGINEERED BACTERIA, AND APPLICATION THEREOF IN PRODUCING D-PSICOSE Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. EPSTEIN, TODD MATTHEW 1652 §103§112 Non-Final OA — Pending Jan 30, 2025
18934156 PLUG-IN BYPASS MODULE FOR A CABLE TV NETWORK DISTRIBUTION TAP Technetix B.V. JIMENEZ, ANTHONY R 2831 §102§112 Non-Final OA — Pending Oct 31, 2024
18853149 A MESENCHYMAL STEM CELLS FORMULATION FOR COSMETIC USE Bright Cell, Inc. VISONE, THOMAS J 1672 §101§102§103§112 Non-Final OA — Pending Oct 01, 2024
18848179 THIN FILM MODIFICATION COMPOSITION, METHOD OF FORMING THIN FILM USING THIN FILM MODIFICATION COMPOSITION, SEMICONDUCTOR SUBSTRATE INCLUDING THIN FILM, AND SEMICONDUCTOR DEVICE INCLUDING SEMICONDUCTOR Soulbrain Co., Ltd. PAGANO, ALEXANDER R 1692 §103 Final Rejection — Pending Sep 18, 2024
18847832 VACUUM-BASED THIN FILM MODIFIER, THIN FILM MODIFICATION COMPOSITION INCLUDING VACUUM-BASED THIN FILM MODIFIER, METHOD OF FORMING THIN FILM USING THIN FILM MODIFICATION COMPOSITION, SEMICONDUCTOR SUBSTRATE INCLUDING THIN FILM, AND SEMICONDUCTOR DEVICE INCLUDING SEMICONDUCTOR SUBSTRATE Soulbrain Co., Ltd. MCDONOUGH, JAMES E 1734 §103 Non-Final OA — Pending Sep 17, 2024
18845669 KIF18A INHIBITOR Wigen Biomedicine Technology (Shanghai) Co., Ltd. KUCHARCZK, JED A 1623 §102§112 Non-Final OA — Pending Sep 10, 2024
18842315 PERMANENT LOCKING MECHANISM FOR AN ADJUSTABLE SEALING SLEEVE Pipetronics GmbH & Co. Kg LEE, MICHAEL S 3677 §103 Final Rejection 72d overdue Pending Aug 28, 2024
18838598 COMPOUND AS FAK INHIBITOR AND USE THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. RAO, SAVITHA M 1691 §101§112 Non-Final OA — Pending Aug 14, 2024
18726997 NANO-COMPOSITE MATERIAL-BASED INTELLIGENT FIREPROOF TEXTILE AND PREPARATION METHOD THEREFOR Soochow University DIAZ, MATTHEW R 1761 §103 Non-Final OA — Pending Jul 05, 2024
18764291 LEVEL SHIFTING CIRCUIT AND LEVEL SHIFTING CIRCUIT AND LEVEL SHIFTING METHOD BASED ON LOW POWER SOURCE Suzhou Mi Tu Optoelectronic Technology Co. Ltd. LAM, TUAN THIEU 2842 §102§103 Non-Final OA 29d Pending Jul 04, 2024
18719549 CONJUGATE FOR PREVENTING AND TREATING VIRAL INFECTIONS AND USE THEREOF Suzhou Ark Biopharmaceutical Co., Ltd. OLSON, ANDREA STEFFEL 1693 §102§103§112DP Non-Final OA — Pending Jun 13, 2024
18706531 COMPOUNDS USED AS SRC INHIBITORS Wigen Biomedicine Technology (Shanghai) Co., Ltd. MAHLUM, JONATHAN DAVIS 1625 §103§112 Non-Final OA — Pending May 01, 2024
18706421 HIGH-STRENGTH FLAME-RETARDANT MXENE/PHOSPHORYLATED CELLULOSE FIBRIL COMPOSITE FILM AND PREPARATION METHOD THEREOF Suzhou Jufeng Electrical Insulation System Co., Ltd. BLEDSOE, JOSHUA CALEB 1762 §103§112 Non-Final OA — Pending May 01, 2024
18704327 ELECTROLYTE AND SECONDARY BATTERY INCLUDING THE SAME Soulbrain Co., Ltd. KASS-MULLET, BENJAMIN ELI 1752 §102§103§112 Non-Final OA — Pending Apr 24, 2024
18703337 A METHOD FOR INDUCING HAPLOIDS AND ITS APPLICATION IN PLANT BREEDING China National Rice Research Institute WILLIAMS, KEITH RICHARD 1663 §112 Non-Final OA — Pending Apr 20, 2024
18701599 SYSTEM AND METHOD FOR ELECTRICALLY STIMULATING TISSUE Synapstim BROWN, KYLE MARTZ 3794 §102§103 Non-Final OA — Pending Apr 15, 2024
18627456 ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME Soulbrain Co., Ltd. CARVALHO JR., ARMINDO 1729 §102§103 Non-Final OA — Pending Apr 05, 2024
18628190 METHOD FOR CONSTRUCTING FINGERPRINT OF XIN SU NING CAPSULE AND FINGERPRINT Shaanxi University Of Science And Technology GO, RICKY 2857 Other Non-Final OA — Pending Apr 05, 2024
18627460 ELECTROLYTE AND SECOND BATTERY COMPRISING SAME Soulbrain Co., Ltd. CARVALHO JR., ARMINDO 1729 §102§103 Non-Final OA — Pending Apr 05, 2024
18627382 ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME Soulbrain Co., Ltd. BERRESFORD, JORDAN ELIZABETH 1727 §102§103 Non-Final OA — Pending Apr 04, 2024
18608048 COMPOSITE POLYMER FILM MATERIAL BASED ON TUNGSTEN/COPPER/SULFUR CLUSTER COMPOUND, PREPARATION METHOD AND USE THEREOF IN THIRD-ORDER NONLINEAR OPTICS Soochow University RHOADES, DEREK JAMES 1692 §101§112 Non-Final OA — Pending Mar 18, 2024
18686864 ULTRASOUND IMAGING USING FOCUSING BEAMS FOR REDUCING MECHANICAL INDEX AND THERMAL INDEX Cloudstream Medical Imaging, Inc. CELESTINE, NYROBI I 3798 §103§112 Final Rejection 56d Pending Feb 26, 2024
18584708 NON-ANIMAL CHONDROITIN SULFATE OLIGOSACCHARIDE AND PREPARATION METHOD THEREOF Jiangnan University GALSTER, SAMUEL LEONARD 1693 §101§102§103§112 Non-Final OA — Pending Feb 22, 2024
18681042 FLOOR CLEANING SYSTEM Suzhou Ruijiu Intelligent Technology Co., Ltd. CARLSON, MARC 3723 §102§103 Final Rejection 21d Pending Feb 03, 2024
18291564 INVERSION OF SOUND SPEED AND POISSON'S RATIO FROM ULTRASOUND BEAM DATA FOR CHARACTERIZATION OF TISSUES Cloudstream Medical Imaging, Inc. MACCHIAROLO, PETER J 2855 §101§112 Final Rejection 9d overdue Pending Jan 23, 2024
18578384 NAPHTHYRIDINE DERIVATIVE AS ATR INHIBITOR AND METHOD FOR PREPARING SAME Wigen Biomedicine Technology (Shanghai) Co., Ltd. NOTTINGHAM, KYLE GREGORY 1621 §103 Final Rejection — Pending Jan 11, 2024
18573908 VEHICULAR GLASS MODULE Nippon Sheet Glass Company, Limited THONG, YEONG JUEN 3761 §102§103 Non-Final OA — Pending Dec 22, 2023
18513586 PREPARATION SYSTEM OF HYDROSOL SOLUTION Jiangsu Aifocus Health Technology Co., Ltd. INSLER, ELIZABETH 1774 §102§103§112 Non-Final OA — Pending Nov 19, 2023
18037553 METHOD FOR PREPARING 2-IODO ARYL ETHER UNDER THE ACTION OF ALKALI METAL HYDRIDE Soochow University CUTLIFF, YATE KAI RENE 1692 §103 Final Rejection — Pending Oct 31, 2023
18288228 FILM-FORMING MATERIAL, FILM-FORMING COMPOSITION, FILM-FORMING METHOD USING FILM-FORMING MATERIAL AND FILM-FORMING COMPOSITION, AND SEMICONDUCTOR DEVICE FABRICATED USING FILM-FORMING METHOD Soulbrain Co., Ltd. RHOADES, DEREK JAMES 1718 §102§112 Non-Final OA — Pending Oct 25, 2023
18381600 FINGERPRINT SPECTRUM CONSTRUCTION METHOD FOR NEW COMPOUND ALOE CAPSULE AND FINGERPRINT SPECTRUM Shaanxi University Of Science And Technology BERA, HENA RAKESHKUMAR 1798 §103§112 Final Rejection — Pending Oct 18, 2023
18277074 AUXILIARY PRECURSOR, THIN-FILM PRECURSOR COMPOSITION, METHOD OF FORMING THIN FILM, AND SEMICONDUCTOR SUBSTRATE FABRICATED USING METHOD Soulbrain Co., Ltd. LIOTT, CAROLINE DUSHECK 1732 §102§103 Final Rejection — Pending Sep 21, 2023
18243187 CABLE NETWORK DEVICE WITH LOW LOSS MEASUREMENT PORT Technetix B.V. BARTOL, LANCE TORBJORN 2843 §103 Non-Final OA 5d Pending Sep 07, 2023
18280666 METAL PARTICLE AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF Suzhou Amart Enterprise Management Co. Ltd. JANSSEN, REBECCA 1733 §103§112 Non-Final OA — Pending Sep 06, 2023
18279127 DEPRESSURIZED MULTILAYERED GLASS PANEL Nippon Sheet Glass Company, Limited EWALD, MARIA VERONICA 1783 §103§112 Non-Final OA 29d Pending Aug 28, 2023
18272084 ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME Soulbrain Co., Ltd. SCHWARTZ, PHILIP N 1749 §103§112 Final Rejection 20d Pending Aug 26, 2023
18272085 ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME Soulbrain Co., Ltd. SCHWARTZ, PHILIP N 1749 §103§112 Final Rejection — Pending Aug 26, 2023
18012645 METHOD FOR SLAG MODIFICATION DURING END PERIOD OF CASTING IN STEEL LADLE HAVING COVER Soochow University MCGUTHRY BANKS, TIMA MICHELE 1733 §112 Non-Final OA — Pending Aug 21, 2023
18275071 SURFACE CLEANING HEAD AND SURFACE CLEANING DEVICE Suzhou Ruijiu Intelligent Technology Co., Ltd. FORDJOUR, SARAH AKYAA 3723 §103 Final Rejection — Pending Jul 31, 2023
18012321 SALVIA PLEBIA AND SCUTELLARIAE RADIX COMPOUND ACNE CREAM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Soochow University AMIN, ALPA NILESH 1655 §102§103§112 Non-Final OA 45d overdue Pending Jul 19, 2023
18272083 ELECTROLYTE SOLUTION AND SECONDARY BATTERY INCLUDING THE SAME Soulbrain Co., Ltd. SCHWARTZ, PHILIP N 1749 §103§112 Final Rejection 22d Pending Jul 12, 2023
18269521 ELECTROLYTE AND SECONDARY BATTERY INCLUDING THE SAME Soulbrain Co., Ltd. LUSTGRAAF, BENJAMIN T 1727 §103 Non-Final OA — Pending Jun 23, 2023
18039229 NOVEL CAMPTOTHECIN DERIVATIVE, COMPOSITION COMPRISING SAME AND USE THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. DEKARSKE, MADELINE MCGUIRE 1622 §103 Final Rejection 13d Pending May 27, 2023
18039206 OXIDE FILM REACTION SURFACE CONTROL AGENT, METHOD OF FORMING OXIDE FILM USING OXIDE FILM REACTION SURFACE CONTROL AGENT, SEMICONDUCTOR SUBSTRATE INCLUDING OXIDE FILM, AND SEMICONDUCTOR DEVICE INCLUDING SEMICONDUCTOR SUBSTRATE Soulbrain Co., Ltd. HOU, FRANK S 1692 §102§112 Non-Final OA — Pending May 26, 2023
18196929 CAPSAICIN-DERIVED PHOTOSENSITIZER, AND PREPARATION METHOD AND USE THEREOF Soochow University BAEK, JONGHWAN NMN 1618 §103 Non-Final OA 34d Pending May 12, 2023

View all 63 →

Managing Szdc Law P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Szdc Law P.C.'s patent allowance rate?

88.7% of resolved applications prosecuted by Szdc Law P.C. were allowed, across 1,422 applications in USPTO records.

How many office actions does Szdc Law P.C. average before allowance?

1.92 office actions per allowed application on average.

How many pending office actions does Szdc Law P.C. have?

63 pending office actions as of October 2026, for 28 clients, before 58 examiners in 48 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month